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Electronic cigarettes: The potential risks outweigh the benefits 
Should the legislation on the sale and promotion of 
electronic cigarettes (e-cigarettes) be similar to that 
for tobacco smoking, or are they different? Is there 
potential medical benefit in their availability and use? I 
shall argue that they should be regulated, based on the 
overwhelming potential for their harm to society, and particularly to 
those that they are intended to ‘help’. Firstly, the evidence for their being 
an effective method for smoking cessation is unconvincing. Secondly, 
they are a means for maintaining nicotine addiction and dependence. 
Thirdly, they may even encourage more habitual use of nicotine, 
which, in time, might encourage a switch to cigarette smoking. Other 
concerns are that their safety has not been proven in large studies of 
long-term use, their effect during pregnancy is unknown, and that 
many e-cigarettes are owned, produced and aggressively promoted by 
the tobacco industry. The tobacco industry has a track record of scant 
concern for the fact that they are promoting the single most important 
preventable cause of malignancy worldwide, apart from their other 
effects. Thus, I will argue that this new ‘vice’ should be subjected to the 
same, if not more rigid, scrutiny applied to tobacco and habit-forming 
drugs before it is released freely to the unsuspecting population. 
Arguably, the only sound justification for physicians to support the 
introduction of e-cigarettes would be if they proved an effective means 
of helping addicted tobacco smokers quit. However, even if they prove 
effective in this, it would have to be shown that they did not do harm by 
convincing new clients that smoking can be safe! Or, as intended by some 
of the manufacturers, acting as gateway devices to cigarette smoking. 
The first priority in healthcare is safety: safety for the user and for 
the bystander. Primary concerns relate to the lack of regulation in 
manufacturing processes in some parts of the world.[1] There are several 
hundred brands of e-cigarettes and certain studies have documented 
e-cigarettes contaminated with diethylene glycol, nitrosamines, 
acetaldehyde and acetone.[1] Although, it is likely that more ‘reputable’ 
brands have stricter manufacturing controls and thus contain only what 
is written on the package insert, these too may not be safe. There are 
data showing acutely increased pulmonary resistance after smoking 
and there is a complete lack of long-term safety data.[2] Furthermore, 
nicotine itself is not entirely safe: it is toxic at high doses, increases insulin 
resistance, is immunosuppressive and directly stimulates pulmonary 
mucus secretion. [3,4] Tobacco smoking was considered to be safe and 
fashionable in the early 1900s, until Richard Doll’s revolutionary work 
in the 1950s showed otherwise.[5] Over 50 million tobacco-related deaths 
are estimated to have occurred in the past 10 years despite us knowing 
full well the harms of tobacco smoke.[6]
What of efficacy? Some convincing data exist that smokers of 
e-cigarettes smoke fewer tobacco cigarettes.[7] There are scant data, 
however, on their efficacy as a bridge to stop smoking.[8] To date, 
the results presented are from small poorly-designed studies with 
inadequate blinding and control/placebo arms, and have shown 
no clear evidence that e-cigarettes assist individuals in stopping 
smoking. The two largest studies, both from the same centre, 
evaluated 27 subjects completing a 6-month study (no control arm) 
and 125 in a 1-year study (unblinded). Thus to date, efficacy and 
safety are based on trial data from a few hundred patients alone.[7,8] 
E-cigarettes are not necessarily cheaper alternatives to tobacco. 
If their use does not result in complete smoking cessation (tobacco 
and e-cigarettes) they may merely perpetuate the financial burden of 
smoking. If marketed as fashionable and progressive, like the hookah 
pipe (‘hubbly-bubbly’), they may additionally yield a new generation 
of e-smokers, chemically addicted to nicotine. Nicotine, although 
not known to be a bridge to narcotic or other drug usage, potentially 
opens the door to chemical tolerance, and long-term users may seek 
increasingly higher nicotine concentrations, ultimately resorting to 
tobacco. E-cigarettes are advocated as a ‘healthier alternative’, but the 
obvious long-term addiction to nicotine remains unaddressed.
E-cigarettes have not been shown to be safe or effective in smoking 
cessation. They contain nicotine, which is toxic and addictive, and 
tobacco companies are selling them. How can they be good? The 
e-cigarette industry needs to be tightly regulated, and independent 
assessment of the harms needs to be made, or we risk replacing one 
evil for another. E-cigarettes may be less dangerous than tobacco, but 
given that tobacco kills 50% of its users, what would not be safer? 
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